Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions

Respiratory motion during PET/CT acquisition can cause misregistration and inaccuracies in calculation of standardized uptake values (SUVs). Our aim was to compare the detection and characterization of thoracic lesions on PET/CT with and without a deep-inspiration protocol. Methods: We studied 15 patients with suspected pulmonary lesions who underwent clinical PET/CT, followed by deep-inspiration breath-hold (BH) PET/CT. In BH CT, the whole chest of the patient was scanned in 15 s at the end of deep inspiration. For BH PET, patients were asked to hold their breath 9 times for 20-s intervals. One radiologist reviewed images, aiming to detect and characterize pulmonary, nodal, and skeletal abnormalities. Clinical CT and BH CT were compared for number, size, and location of lesions. Lesion SUVs were compared between clinical PET and BH PET. Images were also visually assessed for accuracy of fusion and registration. Results: All patients had lesions on clinical CT and BH CT. Pulmonary BH CT detected more lesions than clinical CT in 13 of 15 patients (86.7%). The total number of lung lesions detected increased from 53 with clinical CT to 82 with BH CT (P < 0.001). Eleven patients showed a total of 31 lesions with abnormal 18F-FDG uptake. BH PET/CT had the advantage of reducing misregistration and permitted a better localization of sites with 18F-FDG uptake. A higher SUV was noted in 22 of 31 lesions on BH PET compared with clinical PET, with an average increase in SUV of 14%. Conclusion: BH PET/CT enabled an increased detection and better characterization of thoracic lesions compared with a standard PET/CT protocol, in addition to more precise localization and quantification of the findings. The technique is easy to implement in clinical practice and requires only a minor increase in the examination time.

[1]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[2]  G. V. von Schulthess Positron emission tomography versus positron emission tomography/computed tomography: from "unclear" to "new-clear" medicine. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[3]  Mithat Gonen,et al.  Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  A. Pevsner,et al.  The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  G. Schulthess Positron emission tomography versus positron emission tomography/computed tomography: from "unclear" to "new-clear" medicine. , 2004 .

[6]  E Yorke,et al.  Four-dimensional (4D) PET/CT imaging of the thorax. , 2004, Medical physics.

[7]  Anne-Marie Sykes,et al.  CT screening for lung cancer: five-year prospective experience. , 2005, Radiology.

[8]  C. Ling,et al.  Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer. , 2002, Medical physics.

[9]  Thomas Beyer,et al.  Acquisition protocol considerations for combined PET/CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Theresa C McLoud,et al.  Small pulmonary nodules: detection at chest CT and outcome. , 2003, Radiology.

[11]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[12]  M. Federle,et al.  Positron emission tomography/computed tomography: protocol issues and options. , 2006, Seminars in nuclear medicine.

[13]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[14]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M Schwaiger,et al.  Reproducibility of metabolic measurements in malignant tumors using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[17]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[18]  Heiko Schöder,et al.  Deep-inspiration breath-hold PET/CT of the thorax. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  C. Ling,et al.  Effect of respiratory gating on quantifying PET images of lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Heiko Schöder,et al.  PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Yuji Nakamoto,et al.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Y. Erdi,et al.  Respiratory artefact causing malpositioning of liver dome lesion in right lower lung. , 2003, Clinical nuclear medicine.

[23]  J. Austin,et al.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. , 1996, Radiology.